ZELINI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 364
EU - Europa 293
AS - Asia 179
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 839
Nazione #
US - Stati Uniti d'America 361
CN - Cina 149
IE - Irlanda 98
FI - Finlandia 47
UA - Ucraina 39
IT - Italia 35
DE - Germania 31
SG - Singapore 23
SE - Svezia 20
GB - Regno Unito 13
FR - Francia 4
IN - India 3
BE - Belgio 2
CA - Canada 2
EU - Europa 2
AT - Austria 1
BR - Brasile 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
MX - Messico 1
NL - Olanda 1
NP - Nepal 1
Totale 839
Città #
Dublin 98
Chandler 83
Jacksonville 45
Nanjing 36
Boardman 31
Helsinki 27
Ashburn 25
Beijing 24
Shanghai 19
New York 18
Nanchang 16
Ann Arbor 14
Singapore 13
Lawrence 12
Medford 12
Princeton 12
Wilmington 11
Hebei 9
Jiaxing 8
Munich 8
Shenyang 8
Changsha 6
Woodbridge 6
Seattle 5
Tianjin 5
Hangzhou 4
Milan 4
Pavia 4
Spoleto 4
Marcignago 3
Brussels 2
Des Moines 2
Los Angeles 2
Norwalk 2
San Genesio ed Uniti 2
Toronto 2
Xi'an 2
Bishkek 1
Boves 1
Chorley 1
Dearborn 1
Haikou 1
Hefei 1
Kathmandu 1
Las Vegas 1
London 1
Madrid 1
Mogliano Veneto 1
Naples 1
Porto Alegre 1
Sacramento 1
San Francisco 1
Santa Clara 1
Taizhou 1
Tokyo 1
Verona 1
Vienna 1
Washington 1
Wuhan 1
Zhengzhou 1
Totale 607
Nome #
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 80
Analysis immunohistochemical of the HLA class I molecules in human glioma. 79
Immunohistochemistry and in situ hybridization of “Doppel protein” in human astrocytic tumours 71
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 69
Immunohistochemical expression of HLA antigens and components of the antigen processing machinery in astrocytic tumors. 68
Immunohistochemical and in situ hybridization localization of doppel protein as a new marker astrocytic tumour progression. 66
Doppel protein as a new marker in astrocytic tumour progression 63
Doppel protein as a new marker in astrocytic tumour progression. 58
Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells 54
Human Leukocyte Antigen and antigen processing machinery component defects in astrocytic tumors. 39
Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives 34
Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy 28
Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get" 24
Impact of SARS-CoV-2 infection during pregnancy and persistence of antibody response 22
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 19
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 14
Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get” 12
Dynamics of humoral and cellular immunity elicited by the BNT162b2 mRNA vaccine in psoriatic patients under targeted immunosuppression: A longitudinal cohort study 11
Yet another in vitro evidence that natural compounds introduced by diet have anti-amyloidogenic activities and can counteract neurodegenerative disease depending on aging 11
Correlates of postnatal human cytomegalovirus transmission in term babies in the first year 10
Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children 10
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns 7
Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns 4
Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2 3
Totale 856
Categoria #
all - tutte 4.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 8 2 7 2 17 13 1
2020/202177 7 6 4 7 0 14 1 10 4 11 10 3
2021/202253 2 0 1 1 0 0 1 1 1 3 10 33
2022/2023257 20 20 2 17 21 26 0 12 113 4 17 5
2023/2024159 17 34 9 8 18 34 9 12 1 2 12 3
2024/202576 14 25 15 18 4 0 0 0 0 0 0 0
Totale 856